Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort.

IF 42.1 1区 医学 Q1 ONCOLOGY Journal of Clinical Oncology Pub Date : 2024-08-20 Epub Date: 2024-06-18 DOI:10.1200/JCO.23.02099
José Luis Sandoval, Maria Alice Franzoi, Antonio di Meglio, Arlindo R Ferreira, Alessandro Viansone, Fabrice André, Anne-Laure Martin, Sibille Everhard, Christelle Jouannaud, Marion Fournier, Philippe Rouanet, Laurence Vanlemmens, Asma Dhaini-Merimeche, Baptiste Sauterey, Paul Cottu, Christelle Levy, Silvia Stringhini, Idris Guessous, Ines Vaz-Luis, Gwenn Menvielle
{"title":"Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort.","authors":"José Luis Sandoval, Maria Alice Franzoi, Antonio di Meglio, Arlindo R Ferreira, Alessandro Viansone, Fabrice André, Anne-Laure Martin, Sibille Everhard, Christelle Jouannaud, Marion Fournier, Philippe Rouanet, Laurence Vanlemmens, Asma Dhaini-Merimeche, Baptiste Sauterey, Paul Cottu, Christelle Levy, Silvia Stringhini, Idris Guessous, Ines Vaz-Luis, Gwenn Menvielle","doi":"10.1200/JCO.23.02099","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Socioeconomic status (SES) influences the survival outcomes of patients with early breast cancer (EBC). However, limited research investigates social inequalities in their quality of life (QoL). This study examines the socioeconomic inequalities in QoL after an EBC diagnosis and their time trends.</p><p><strong>Patients and methods: </strong>We used data from the French prospective multicentric CANTO cohort (ClinicalTrials.gov identifier: NCT01993498), including women with EBC enrolled between 2012 and 2018. QoL was assessed using the European Organisation for Research and Treatment of Cancer QoL Core 30 questionnaire (QLQ-C30). summary score at diagnosis and 1 and 2 years postdiagnosis. We considered three indicators of SES separately: self-reported financial difficulties, household income, and educational level. We first analyzed the trajectories of the QLQ-C30 summary score by SES group. Then, social inequalities in QLQ-C30 summary score and their time trends were quantified using the regression-based slope index of inequality (SII), representing the absolute change in the outcome along socioeconomic gradient extremes. The analyses were adjusted for age at diagnosis, Charlson Comorbidity Index, disease stage, and type of local and systemic treatment.</p><p><strong>Results: </strong>Among the 5,915 included patients with data on QoL at diagnosis and at the 2-year follow-up, social inequalities in QLQ-C30 summary score at baseline were statistically significant for all SES indicators (SII<sub>financial difficulties</sub> = -7.6 [-8.9; -6.2], SII<sub>income</sub> = -4.0 [-5.2; -2.8]), SII<sub>education</sub> = -1.9 [-3.1; -0.7]). These inequalities significantly increased (interaction <i>P</i> < .05) in year 1 and year 2 postdiagnosis, irrespective of prediagnosis health, tumor characteristics, and treatment. Similar results were observed in subgroups defined by menopausal status and type of adjuvant systemic treatment.</p><p><strong>Conclusion: </strong>The magnitude of preexisting inequalities in QoL increased over time after EBC diagnosis, emphasizing the importance of considering social determinants of health during comprehensive cancer care planning.</p>","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":null,"pages":null},"PeriodicalIF":42.1000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11328924/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/JCO.23.02099","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Socioeconomic status (SES) influences the survival outcomes of patients with early breast cancer (EBC). However, limited research investigates social inequalities in their quality of life (QoL). This study examines the socioeconomic inequalities in QoL after an EBC diagnosis and their time trends.

Patients and methods: We used data from the French prospective multicentric CANTO cohort (ClinicalTrials.gov identifier: NCT01993498), including women with EBC enrolled between 2012 and 2018. QoL was assessed using the European Organisation for Research and Treatment of Cancer QoL Core 30 questionnaire (QLQ-C30). summary score at diagnosis and 1 and 2 years postdiagnosis. We considered three indicators of SES separately: self-reported financial difficulties, household income, and educational level. We first analyzed the trajectories of the QLQ-C30 summary score by SES group. Then, social inequalities in QLQ-C30 summary score and their time trends were quantified using the regression-based slope index of inequality (SII), representing the absolute change in the outcome along socioeconomic gradient extremes. The analyses were adjusted for age at diagnosis, Charlson Comorbidity Index, disease stage, and type of local and systemic treatment.

Results: Among the 5,915 included patients with data on QoL at diagnosis and at the 2-year follow-up, social inequalities in QLQ-C30 summary score at baseline were statistically significant for all SES indicators (SIIfinancial difficulties = -7.6 [-8.9; -6.2], SIIincome = -4.0 [-5.2; -2.8]), SIIeducation = -1.9 [-3.1; -0.7]). These inequalities significantly increased (interaction P < .05) in year 1 and year 2 postdiagnosis, irrespective of prediagnosis health, tumor characteristics, and treatment. Similar results were observed in subgroups defined by menopausal status and type of adjuvant systemic treatment.

Conclusion: The magnitude of preexisting inequalities in QoL increased over time after EBC diagnosis, emphasizing the importance of considering social determinants of health during comprehensive cancer care planning.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
早期乳腺癌术后生活质量方面社会经济不平等的程度和时间变化:来自法国 CANTO 多中心队列的结果。
目的:社会经济地位(SES)会影响早期乳腺癌(EBC)患者的生存结果。然而,有关其生活质量(QoL)的社会不平等现象的研究却十分有限。本研究探讨了确诊 EBC 后生活质量方面的社会经济不平等现象及其时间趋势:我们使用了法国前瞻性多中心 CANTO 队列(ClinicalTrials.gov 标识符:NCT01993498)的数据,包括 2012 年至 2018 年间入组的 EBC 女性患者。QoL采用欧洲癌症研究和治疗组织QoL核心30问卷(QLQ-C30)进行评估。我们分别考虑了三个 SES 指标:自我报告的经济困难、家庭收入和教育水平。我们首先按社会经济地位分组分析了 QLQ-C30 总分的变化轨迹。然后,使用基于回归的不平等斜率指数(SII)对 QLQ-C30 总分的社会不平等及其时间趋势进行量化,该指数代表了结果在社会经济梯度极端上的绝对变化。分析对诊断时的年龄、夏尔森综合症指数、疾病分期以及局部和全身治疗类型进行了调整:在 5915 名诊断时和两年随访时均有 QoL 数据的纳入患者中,基线 QLQ-C30 总分的社会不平等在所有 SES 指标(SII 经济困难 = -7.6 [-8.9; -6.2],SII 收入 = -4.0 [-5.2; -2.8])和 SII 教育 = -1.9 [-3.1; -0.7])上均有统计学意义。无论诊断前的健康状况、肿瘤特征和治疗情况如何,这些不平等在诊断后第 1 年和第 2 年都明显增加(交互作用 P < .05)。在根据绝经状态和辅助系统治疗类型划分的亚组中也观察到了类似的结果:结论:EBC确诊后,原有的QoL不平等程度会随着时间的推移而增加,这强调了在制定癌症综合治疗计划时考虑健康的社会决定因素的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Clinical Oncology
Journal of Clinical Oncology 医学-肿瘤学
CiteScore
41.20
自引率
2.20%
发文量
8215
审稿时长
2 months
期刊介绍: The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.
期刊最新文献
Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data Availability. Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial. Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round. How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3-Mutated AML? Reply to S. Fuji.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1